Related references
Note: Only part of the references are listed.Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation
Yuan Su et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Unexpected implications of STAT3 acetylation revealed by genetic encoding of acetyl-lysine
Yael Belo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
The long non-coding RNA LncHDAC2 drives the self-renewal of liver cancer stem cells via activation of Hedgehog signaling
Jiayi Wu et al.
JOURNAL OF HEPATOLOGY (2019)
Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8
Shana V. Stoddard et al.
MOLECULAR INFORMATICS (2019)
Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer
Jun Zhao et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)
Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity
Hanxun Wang et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)
Expression of Class IHistone Deacetylases in Ipsilateral and Contralateral Hemispheres after the Focal Photothrombotic Infarction in the Mouse Brain
Svetlana Demyanenko et al.
TRANSLATIONAL STROKE RESEARCH (2018)
Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas
Melis Kayikci et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas
Melis Kayikci et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Assessing the Performance of MM/PBSA, MM/GBSA, and QM-MM/GBSA Approaches on Protein/Carbohydrate Complexes: Effect of Implicit Solvent Models, QM Methods, and Entropic Contributions
Sushil K. Mishra et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim et al.
LANCET ONCOLOGY (2018)
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6
Marta De Donato et al.
SCIENTIFIC REPORTS (2018)
Prediction of Accurate Binding Modes Using Combination of Classical and Accelerated Molecular Dynamics and Free-Energy Perturbation Calculations: An Application to Toxicity Studies
Filip Fratev et al.
ACS OMEGA (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Panobinostat
Mathilde Van Veggel et al.
CLINICAL PHARMACOKINETICS (2018)
Molecular Basis of Substrate Recognition and Product Release by the Klebsiella pneumoniae Carbapenemase (KPC-2)
Orville A. Pemberton et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Chemical and structural biology of protein lysine deacetylases
Minoru Yoshida et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Insight Mechanism of the Selective Lanosterol Synthase Inhibitor: Molecular Modeling, Docking and Density Functional Theory Approaches
Subramanian Karunagaran et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors
Florence F. Wagner et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Inside HDACs with more selective HDAC inhibitors
Joelle Roche et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
HDAC2 Provides a Critical Support to Malignant Progression of Hepatocellular Carcinoma through Feedback Control of mTORC1 and AKT
Ji Heon Noh et al.
CANCER RESEARCH (2014)
Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer
Hyung S. Kim et al.
FEBS JOURNAL (2014)
A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests
Frederick A. Schroeder et al.
PLOS ONE (2013)
Inside HDAC with HDAC inhibitors
Philippe Bertrand
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Epigenetic control of skull morphogenesis by histone deacetylase 8
Michael Haberland et al.
GENES & DEVELOPMENT (2009)
A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
S. Balasubramanian et al.
LEUKEMIA (2008)
Histone deacetylase inhibitors: Overview and perspectives
Milos Dokmanovic et al.
MOLECULAR CANCER RESEARCH (2007)
Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex
Alessandro Vannini et al.
EMBO REPORTS (2007)
Histone deacetylase inhibitors in cancer therapy
Walid K. Rasheed et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Paola Gallinari et al.
CELL RESEARCH (2007)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
A combined QM/MM approach to protein-ligand interactions:: Polarization effects of the HIV-1 protease on selected high affinity inhibitors
C Hensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Acetylation of proteins as novel target for antitumor therapy: Review article
E Di Gennaro et al.
AMINO ACIDS (2004)
Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RaIGDS complexes
H Gohlke et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Share Paper
